PARLIAMENTARY WRITTEN QUESTION
Kidney Cancer (8 June 2022)
Question Asked
Asked by:
Laura Trott (Conservative)
Answer
There are no current plans for the National Institute for Health and Care Excellence (NICE) to develop a guideline or quality standard on kidney cancer. However, NICE has recommended a number of medicines for the treatment of renal cell carcinoma through its technology appraisal programme, which are now routinely available to National Health Service patients. NICE has also has made recommendations on the referral of people patients with possible symptoms of renal cancer for further investigation in its guideline on suspected cancer. Where a NICE guideline or quality standard does not exist, clinicians should take into account other sources of clinical guidance.
Answered by:
Edward Argar (Conservative)
22 June 2022
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.